Pacgen Life Science Corporation is a Canada-based life science technology company. The Company is focused on the commercialization of biomedical products and services, including its previous development of novel therapeutic drug candidates. The Company’s products include: Fit X1, Electronic Pipettes and A+ Pipette Controller. Fit X 401 is an automated, high-precision pipetting system specifically designed to replace the manual process of PCR/qPCR sample preparation. A+ Pipette Controller is an electronic pipette controller designed for use with graduated and volumetric glass and plastic pipets. The Company has reported positive results from its Phase IIb dose-ranging clinical trial for its lead product candidate, PAC-113, a novel anti-fungal drug.